AI news
公司内部站点 · 页面资源保存在本地(2026-10-17 06:48 UTC)· 独立 X 采集尚未配置;互动计数仅限本站

Amazon Bio Discovery develops three AI approaches for antibody drug design

Amazon Science

Amazon Science said Amazon Bio Discovery developed three AI approaches to accelerate antibody drug design: MochiBind for sequence-based affinity ranking, CA-MAP for developability prediction with batch effect correction, and an agent-guided design system.

The agent-guided system was described as producing 46 lab-validated hits against a novel cancer target. Amazon Science linked additional details at amazon.science.